Clinical Trials

300 enrolled

Phase 2/3 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03637816 2026-04-15

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

25 enrolled

Phase NA Active not recruiting

Anorexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03731585 2026-04-15

Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment

70 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03948100 2026-04-15

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Phase 1/2 Active not recruiting

400 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms

NCT05616624 2026-04-15

ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers

31 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT06688422 2026-04-15

INSPIRE-CRT

100 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonia

NCT07020065 2026-04-15

Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%

156 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07288034 2026-04-15

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

535 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01118676 2026-04-14

Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

Phase 1 Completed

14 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06992739 2026-04-14

PROTECT-2

49 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07528274 2026-04-14

Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07529145 2026-04-14

Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment

Recruiting

90 enrolled

Other hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT05106374 2026-04-13

Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer

Completed

182 enrolled

Carcinoma, Non-Small-Cell Lung, Hematologic Neoplasms

NCT05553834 2026-04-13

PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung

Phase 2 Active not recruiting

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06477055 2026-04-13

RAISE

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06552234 2026-04-13

REPOROS

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06660407 2026-04-13

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07104630 2026-04-13

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

85 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07195084 2026-04-13

HyPROS-LC

12 enrolled

DermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung

NCT03236935 2026-04-09

Phase Ib of L-NMMA and Pembrolizumab

Phase 1 Completed

12 enrolled 15 charts

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, DNA Repair-Deficiency Disorders

NCT03523702 2026-04-09

SPRINT

Phase 2 Completed

25 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT05445791 2026-04-09

METLUNG

Phase 3 Recruiting

312 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05852990 2026-04-09

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Phase 3 Recruiting

28 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06238882 2026-04-09

Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.

Phase 4 Active not recruiting

74 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT06282874 2026-04-09

Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases

41 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT03803787 2026-04-08

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

72 enrolled

Radiation Fibrosis Syndrome, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Radiation Pneumonitis, Lung Injury

NCT04317534 2026-04-08

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

244 enrolled